Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus.

about

Involvement of soluble B7-H3 in combination with the serum inflammatory cytokines interleukin-17, -8 and -6 in the diagnosis of hepatocellular carcinoma.Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.

P2860

Q49320250-C88CF256-2C3B-423D-B653-C11788445EDE Q50115667-01F3CCB1-D369-4483-AE39-601C749D1B03

P2860

Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus.

Item

http://www.wikidata.org/entity/Q38635840

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Enhancing antitumor immunogeni ...... n L1 of Bovine papillomavirus.

@en

type

Item

label

Enhancing antitumor immunogeni ...... n L1 of Bovine papillomavirus.

@en

prefLabel

Enhancing antitumor immunogeni ...... n L1 of Bovine papillomavirus.

@en

P1476

Enhancing antitumor immunogeni ...... n L1 of Bovine papillomavirus.

@en

P2093

Andrew Yang

http://www.w3.org/2001/XMLSchema#string

Emily Farmer

http://www.w3.org/2001/XMLSchema#string

Qi Zeng

http://www.w3.org/2001/XMLSchema#string

Shiwen Peng

http://www.w3.org/2001/XMLSchema#string

T-C Wu

http://www.w3.org/2001/XMLSchema#string

Xiaowu Pang

http://www.w3.org/2001/XMLSchema#string

P2860

Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research

Clinical significance of human papillomavirus genotyping

Perspectives for therapeutic HPV vaccine development

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells.

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.

Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen

Multivalent human papillomavirus l1 DNA vaccination utilizing electroporation.

Cancer immunotherapy employing an innovative strategy to enhance CD4+ T cell help in the tumor microenvironment

Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine Papillomavirus-HIV-1 gp41 chimeric virus-like particles

P2888

s13578-017-0171-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13578-017-0171-5

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Max A Cheng

Chien-Fu Hung

P577

2017-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091327431

http://www.w3.org/2001/XMLSchema#string

P698

28852471

http://www.w3.org/2001/XMLSchema#string

P932

5569540

http://www.w3.org/2001/XMLSchema#string

Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus.

about

P2860

P2860

Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P932